Publications by authors named "Olga Panova"
Article Synopsis
- - The study assesses giardiasis, a common protozoal disease in dogs and cats, focusing on its prevalence and age susceptibility in domestic pets.
- - It involved microscopic examination of fecal samples from over 4000 dogs and cats, noting stool characteristics alongside age data.
- - Findings revealed higher infection rates in younger animals (under 12 months) and highlighted soft or mushy stools and strong odors as common symptoms, emphasizing the need for ongoing health checks in seemingly healthy pets.
Background And Aim: Anthelmintics are used to control equine nematodes. However, helminth resistance to regularly used drugs is a well-known challenge. Among tests to assess effective control and monitor resistance, the most common is the fecal egg count reduction test (FECRT).
View Article and Find Full Text PDFThe detection of cardiac biomarkers is used for diagnostics, prognostics, and the risk assessment of cardiovascular diseases. The analysis of cardiac biomarkers is routinely performed with high-sensitivity immunological assays. Aptamers offer an attractive alternative to antibodies for analytical applications but, to date, are not widely practically implemented in diagnostics and medicinal research.
View Article and Find Full Text PDFTo find out the transmission routes for Toxocara infection, the possibility of transfer of Toxocara eggs from the soil on the paws of animals and on the shoes of people was explored. For this purpose, a study was conducted to find helminth eggs in washings from the paws of dogs after walking, from the shoes of their owners, as well as non-dog owners. Toxocara eggs were detected in 19.
View Article and Find Full Text PDFIntroduction: IncobotulinumtoxinA (Xeomin®/Xeomeen®/Bocouture®/XEOMIN Cosmetic™; botulinum toxin type A, free from complexing proteins [150 kDa], NT 201; Merz Pharmaceuticals GmbH, Frankfurt, Germany) is an effective and well-tolerated treatment for a variety of facial wrinkles.
Objective: To determine the efficacy and safety of incobotulinumtoxinA for the treatment of platysmal bands.
Methods: Women, 35-65 years of age, with platysmal bands scoring 2 or 3 on the validated 5-point Merz dynamic platysmal bands scale received a total of 60 U incobotulinumtoxinA divided between four platysmal bands (20 U in both medial bands and 10 U in both lateral bands).